As Illumina’s deSouza departs, will Grail go next?

The abrupt resignation of Illumina CEO Francis deSouza, less than a month after a proxy battle led by activist investor Carl Icahn helped persuade shareholders to oust the company’s chairman, signals a change of direction at the gene sequencing pioneer.